May 11, 2023 Sophia Vida

Emergent Health Subsidiary Evolutionary Biologics Executes Product Manufacturing Agreement with Major Player in the Regenerative Medicine Space

Expected to Generate at least $2 Million in New Revenue New York, NY, May 11, 2023 – McapMediaWire – Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced that its subsidiary Evolutionary Biologics, Inc. (“EvoBio”), a developer, manufacturer and distributor of private label regenerative medicine products and branded … Continue reading “Emergent Health Subsidiary Evolutionary Biologics Executes Product Manufacturing Agreement with Major Player in the Regenerative Medicine Space”